8Sefa Resim,Hasan Ekerbicer,Ahmet Ciftci.Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus[J].International Journal of Urology,2005,12(1):615-620.
9Michel MC,de la Rosette JJ.Efficacy and safety of tamsulosin in the treatment of urological diseases[J].Expert Opin Pharmacother,2004,5(1):151.
二级参考文献7
1Tewari A,Narayan P.Alpha-adrenergic blocking drugs in the management of benign prostatic hyperplasia: interactions with antihypertensive therapy[].Urology.1999
2Lowe FC.Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect[].Clinical Therapeutics.1997
3Chapple CR.Selectiveα1-adrenoceptor antagonist in benign prostatic hyperplasia: rationale and clinical experience[].European Urology.1996
4Veld AJ.Symptomatic BPH and hypertention: does comorbidity affect quality of life[].European Urology.1998
5Walma EP,Hoes AW,van Dooren C,et al.Withdrawal of longterm diuretic medication in elderly patients: a double blind randomised trial[].British Medical Journal.1997
6Kawabe K.Current status of research on prostate-selectiveα1 antagonists[].British Journal of Urology.1998
7Schulman CC,Cortvriend J,Jonas U,et al.Tamsulosin, the first prostate-selectiveα1A-adrenoceptor antagonist.Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction(symptomatic BPH)[].European Urology.1996
